Evidence map›Paper›PMID 26069184›Full record

ArticleJournal of neurovirology2016

Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.

Xianzhi Jiang, Don Brown, Nelson Osorio, Chinhui Hsiang, Lbachir BenMohamed, Steven L Wechsler

Abstract read
In one paragraph

Article in Journal of neurovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. MicroRNAs in Ocular Infection.Microorganisms · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xianzhi JiangVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA.
Don BrownVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA.
Nelson OsorioVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA.
Chinhui HsiangVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA.
Lbachir BenMohamedVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA.
Steven L WechslerVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, University of California Irvine, School of Medicine, Irvine, CA, 92697, USA. Wechsler@uci.edu.

Funding

Corneal HSV-1: LAT's Anti-Apoptosis Activity and LatencyR01EY013191 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2001 to 2013
$6.9M
Therapeutic Ocular HSV Vaccine in HLA Transgenic RabbitsR01EY019896 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2010 to 2025
$5.1M
Ocular Mucsoal Immunity Induced by HSV-1 LipopeptidesR01EY014900 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2003 to 2014
$3.1M
Mechanisms of CD8+ T Cell Dynamics in Recurrent Ocular Herpetic DiseaseR01EY026103 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2016 to 2019
$1.5M
Blockade of T-cell Co-Inhibitory Pathways & Immunotherapy to Prevent Ocular HerpeR01EY024618 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2014 to 2016
$1.2M
HSV-1 LAT miRNAs: Neurovirulence, reactivation, mechanismR56AI098985 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2013 to 2013
$421k
Corneal HSV-1: Newly discovered LAT miRNAs and latencyR56AI093133 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2011 to 2011
$383k
NEI NIH HHS EY024618NEI NIH HHS R01 EY013191NEI NIH HHS R01EY013191NEI NIH HHS R01 EY014900NEI NIH HHS R01 EY019896NEI NIH HHS R01EY019896NEI NIH HHS R01 EY024618NEI NIH HHS R01 EY026103NEI NIH HHS R01EY14900NIAID NIH HHS 1R56AI093133NIAID NIH HHS 1R56AI098985NIAID NIH HHS R56 AI093133NIAID NIH HHS R56 AI098985
6 · The paper itself

Abstract

At least six microRNAs (miRNAs) appear to be encoded by the latency-associated transcript (LAT) of herpes simplex virus type 1 (HSV-1). The gene for ICP0, an important immediate early (IE) viral protein, is anti-sense to, and overlaps with, the region of LAT from which miRNA H2 (miR-H2) is derived. We recently reported that a mutant (McK-ΔH2) disrupted for miR-H2 on the wild-type HSV-1 strain McKrae genomic background has increased ICP0 expression, increased neurovirulence, and slightly more rapid reactivation. We report here that HSV-1 mutants deleted for the LAT promoter nonetheless make significant amounts of miR-H2 during lytic tissue culture infection, presumably via readthrough transcription from an upstream promoter. To determine if miR-H2 might also play a role in the HSV-1 latency/reactivation cycle of a LAT-negative mutant, we constructed dLAT-ΔH2, in which miR-H2 is disrupted in dLAT2903 without altering the predicted amino acid sequence of the overlapping ICP0 open reading frame. Similar to McK-ΔH2, dLAT-ΔH2 expressed more ICP0, was more neurovirulent, and had increased reactivation in the mouse TG explant-induced reactivation model of HSV-1 compared with its parental virus. Interestingly, although the increased reactivation of McK-ΔH2 compared with its parental wild-type (wt) virus was subtle and only detected at very early times after explant TG induced reactivation, the increased reactivation of dLAT-ΔH2 compared with its dLAT2903 parental virus appeared more robust and was significantly increased even at late times after induction. These results confirm that miR-H2 plays a role in modulating the HSV-1 reactivation phenotype.

Indexed as

AnimalsCell Line, TumorDisease Models, AnimalFemaleGene Expression Regulation, ViralHerpes SimplexHerpesvirus 1, HumanHumansImmediate-Early ProteinsMiceMicroRNAsNeuronsPromoter Regions, GeneticRNA, ViralTissue Culture TechniquesTrigeminal GanglionImmediate-Early Proteinslatency associated transcript, herpes simplex virus-1MicroRNAsRNA, ViralUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1HSV-1LatencyLAT microRNAmiR-H2Reactivation

Identifiers

PMID26069184
PMCPMC4676951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.